Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anne-Tiina Lahdenkari"'
Autor:
Maija Suvanto, Eero Kajantie, Anne-Tiina Lahdenkari, Marjo Kestilä, Hannu Jalanko, Olli Koskimies
Publikováno v:
Pediatric Nephrology. 20:1073-1080
The pathogenesis of minimal change nephrotic syndrome (MCNS) is still unknown. We performed a clinical and genetic evaluation of 104 adults (mean age 35 years) who presented with MCNS in childhood (mean follow-up 30 years). Clinical data and the pres
Publikováno v:
Kidney International. 65:1856-1863
Nephrin gene (NPHS1) in patients with minimal change nephrotic syndrome (MCNS). Background. Minimal change nephrotic syndrome (MCNS) is a major problem in pediatric nephrology. While the pathogen- esis of MCNS is not known, the latest discoveries in
Autor:
Olli Koskimies, Jaakko Patrakka, Jorma Wartiovaara, Hannu Jalanko, Anne-Tiina Lahdenkari, Christer Holmberg
Publikováno v:
Pediatric Research. 52:349-355
The pathophysiology of proteinuria in acquired kidney diseases is mostly unknown. Recent findings in genetic renal diseases suggest that glomerular epithelial cells (podocytes) and the slit diaphragm connecting the podocyte foot processes play an imp
Autor:
Jussi Merenmies, Riitta Karikoski, Juhani Rapola, Hannu Jalanko, Kaija Salmela, Christer Holmberg, Anne-Tiina Lahdenkari, Arvi-Matti Kuusniemi
Publikováno v:
Kidney international. 70(8)
Congenital nephrotic syndrome of the Finnish type (NPHS1) is a rare genetic disease caused by mutations in the NPHS1 gene encoding a major podocyte slit-diaphragm protein, nephrin. Patients with NPHS1 have severe nephrotic syndrome from birth and dev
Autor:
Riitta Karikoski, Karl Tryggvason, Arvi-Matti Kuusniemi, Vesa Ruotsalainen, Riitta Salonen, Christer Holmberg, Marjo Kestilä, Hannu Jalanko, Anne-Tiina Lahdenkari, Jaakko Patrakka
Publikováno v:
Pediatric research. 55(5)
Nephrin is a major component of the glomerular filtration barrier. Mutations in the nephrin gene (NPHS1) are responsible for congenital nephrotic syndrome of the Finnish type (NPHS1). Nephrin was at first thought to be podocyte specific, but recent s
Autor:
Jorma Viikari, Kati Ylitalo, Marjatta Antikainen, Leena Suurinkeroinen, M. Perola, Mikko Syvänne, Marja-Riitta Taskinen, Päivi Pajukanta, Christian Ehnholm, Ilpo Nuotio, Olli T. Raitakari, Leena Peltonen, Petri T. Kovanen, Anne-Tiina Lahdenkari, S. Lahdenperä, Terho Lehtimäki, Kimmo Porkka
Publikováno v:
Atherosclerosis. 133(2)
Familial combined hyperlipidaemia (FCHL) is one of the most common hereditary disorders predisposing to early coronary death. The affected family members have elevations of serum total cholesterol, triglycerides or both. Despite intensive research ef
Autor:
Leena Peltonen, Marjatta Antikainen, Sanna Murtomäki-Repo, Jorma Viikari, Leena Suurinkeroinen, Christian Ehnholm, Ilpo Nuotio, Anne-Tiina Lahdenkari, Marja-Riitta Taskinen, Sonja Ehnholm, Markus Perola, Päivi Pajukanta, Ann-Christine Syvänen, Kimmo Porkka
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 17(5)
Abstract Familial combined hyperlipidemia (FCHL) is characterized by different lipid phenotypes (IIa, IIb, IV) and elevated apolipoprotein B (apo B) levels in affected family members. Despite intensive research, the genes involved in the expression o